Results 121 to 130 of about 259 (175)

Successful Rapid Desensitization to Ceftazidime/Avibactam in a Patient With Cystic Fibrosis and Multidrug‐Resistant Pseudomonas aeruginosa Pneumonia: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Ceftazidime/avibactam (CAZ‐AVI) is an important therapeutic option for multidrug‐resistant (MDR) Pseudomonas aeruginosa infections; however, hypersensitivity reactions may preclude its use and create significant therapeutic challenges. We report a 21‐year‐old woman with cystic fibrosis and recurrent MDR P.
Zuoren Zhou   +6 more
wiley   +1 more source

Improvement of Fibromyalgia by Immunoglobulin/Histamine Complex Therapy for Chronic Urticaria and Allergic Rhinitis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Fibromyalgia (FM) is a chronic pain syndrome characterized by widespread musculoskeletal pain, often accompanied by fatigue, sleep disturbance, and cognitive symptoms. Although several treatment options are available, no curative therapy has been established.
Hyuk Soon Kim   +3 more
wiley   +1 more source

Dupilumab Combined With House Dust Mite Allergen Immunotherapy for Atopic Dermatitis: A Systematic Review and Meta‐Analysis

open access: yesClinical and Translational Allergy, Volume 16, Issue 8, August 2026.
ABSTRACT Background Dupilumab is effective for moderate‐to‐severe atopic dermatitis (AD), but sustained disease control after treatment discontinuation remains challenging. House dust mite allergen immunotherapy (HDM‐AIT) may provide disease‐modifying effects in sensitized patients, but the added value of combining HDM‐AIT with dupilumab remains ...
Jiale Lian   +3 more
wiley   +1 more source

New Insights Into Immunomodulatory Strategies for Drug Hypersensitivity Reactions: An EAACI Task Force Report

open access: yesClinical and Translational Allergy, Volume 16, Issue 8, August 2026.
ABSTRACT Drug hypersensitivity reactions (DHRs) are a global health concern and remain challenging to investigate owing to the heterogeneity of endotypes and phenotypes, as well as the lack of standardized biomarkers. Until recently, strict drug avoidance was the only management strategy for severe DHRs.
Ana Maria Copaescu   +13 more
wiley   +1 more source

Open‐Label, Balanced, Randomized, Single‐Dose, Three‐Treatment, Three‐Sequence, Three‐Period, Three‐Way Crossover Oral Bioequivalence Study of Desmopressin Acetate Oral Solution

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 8, August 2026.
ABSTRACT Desmopressin is first‐line therapy for central diabetes insipidus, also known as arginine vasopressin deficiency, but presents dosing challenges due to its narrow therapeutic index. This open‐label, randomized, three‐way crossover study evaluated the bioequivalence of a new desmopressin acetate oral solution (50 mcg/mL) compared to ...
Adam Christensen   +5 more
wiley   +1 more source

The Efficacy of Omalizumab Therapy in Chronic Inducible Urticaria

open access: yesJournal of the Turkish Academy of Dermatology, 2022
Özge Aşkın   +3 more
openaire   +1 more source

Angioedema in Primary Care: Disease Course and Its Relation to ACE Inhibitor Use

open access: yes
International Journal of Dermatology, Volume 65, Issue 9, Page 1910-1912, September 2026.
Reineke Soegiharto   +6 more
wiley   +1 more source

Total Protein and 10‐Hydroxy‐2‐Decenoic Acid Content, In Vitro Bioaccessibility, Antibacterial, and Antidiabetic Properties of Royal Jelly Collected at Different Harvesting Times

open access: yesFood Science &Nutrition, Volume 14, Issue 8, August 2026.
In this study, the total protein content and 10‐hydroxy‐2‐decenoic acid content were determined in royal jelly collected at the 72 and 144 h. In vitro bioaccessibility, antibacterial, and antidiabetic properties of royal jelly collected at the 72 and 144 h were also determined. ABSTRACT Royal jelly has received interest as a functional food.
Eyuel Welelaw   +9 more
wiley   +1 more source

Assessment of Allergenic Potential for Cross‐Reactivity of Olive (Olea europaea) Pit Xylo‐Oligosaccharide‐Rich Extract With Legislated Allergens in the European Union

open access: yesFood Science &Nutrition, Volume 14, Issue 8, August 2026.
Spray‐dried xylo‐oligosaccharide‐rich extract derived from olive pit endocarps was assessed for potential cross‐reactivity using in vitro ELISA and in silico approaches. The ELISA tests indicated potential cross‐reactivities with nuts (hazelnut, almond, pistachio, peanut), gluten, and milk in certain batches.
Maame Ekua Manful   +4 more
wiley   +1 more source

Prevalence and Risk Factors of Food Allergy and Its Association With Asthma Coexistence and Severity in Bangladeshi Schoolchildren: A GIS‐Based Cross‐Sectional Study

open access: yesFood Science &Nutrition, Volume 14, Issue 8, August 2026.
This nationwide study revealed a high prevalence of food allergies (29.3%) and asthma (15.9%) among Bangladeshi schoolchildren, with frequent coexistence and greater severity in certain regions highlighting the urgent need for targeted awareness, early diagnosis, and region‐specific interventions.
Nitai Roy   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy